WO2000040759A3 - Uses of flavivirus rna-dependent rna polymerases - Google Patents
Uses of flavivirus rna-dependent rna polymerases Download PDFInfo
- Publication number
- WO2000040759A3 WO2000040759A3 PCT/US2000/000152 US0000152W WO0040759A3 WO 2000040759 A3 WO2000040759 A3 WO 2000040759A3 US 0000152 W US0000152 W US 0000152W WO 0040759 A3 WO0040759 A3 WO 0040759A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- rna
- flavivirus
- polymerases
- dependent
- dependent rna
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU24053/00A AU2405300A (en) | 1999-01-05 | 2000-01-05 | Uses of flavivirus rna-dependent rna polymerases |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11477999P | 1999-01-05 | 1999-01-05 | |
US60/114,779 | 1999-01-05 | ||
US47484799A | 1999-12-30 | 1999-12-30 | |
US09/474,847 | 1999-12-30 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2000040759A2 WO2000040759A2 (en) | 2000-07-13 |
WO2000040759A3 true WO2000040759A3 (en) | 2000-11-23 |
WO2000040759A9 WO2000040759A9 (en) | 2001-10-11 |
Family
ID=26812534
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/000152 WO2000040759A2 (en) | 1999-01-05 | 2000-01-05 | Uses of flavivirus rna-dependent rna polymerases |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2405300A (en) |
WO (1) | WO2000040759A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000033635A2 (en) * | 1998-12-10 | 2000-06-15 | Eli Lilly And Company | Primer-independent rna synthesis catalyzed by hcv polymerase |
CA2560699A1 (en) * | 2004-03-24 | 2005-10-13 | Achillion Pharmaceuticals, Inc. | Quantitative assay for detection of newly synthesized rna in a cell-free system and identification of rna synthesis inhibitors |
US20200157513A1 (en) * | 2017-04-10 | 2020-05-21 | The Penn State Research Foundation | Compositions and methods comprising viral reverse transcriptase |
WO2021231891A1 (en) * | 2020-05-15 | 2021-11-18 | Quidel Corporation | Method for direct amplification and detection of rna |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5364760A (en) * | 1986-04-16 | 1994-11-15 | The Salk Institute For Biological Studies | Replicative RNA reporter systems |
WO1998031789A1 (en) * | 1997-01-16 | 1998-07-23 | Scriptgen Pharmaceuticals, Inc. | Nucleic acid encoding m. tuberculosis algu protein |
-
2000
- 2000-01-05 WO PCT/US2000/000152 patent/WO2000040759A2/en active Application Filing
- 2000-01-05 AU AU24053/00A patent/AU2405300A/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5364760A (en) * | 1986-04-16 | 1994-11-15 | The Salk Institute For Biological Studies | Replicative RNA reporter systems |
WO1998031789A1 (en) * | 1997-01-16 | 1998-07-23 | Scriptgen Pharmaceuticals, Inc. | Nucleic acid encoding m. tuberculosis algu protein |
Non-Patent Citations (4)
Title |
---|
KAO C C &SUN J-H: "Initiation of minus-strand RNA synthesis by the brome mosaic virus RNA-dependent RNA polymerase: use of oligoribonucleotide primers", JOURNAL OF VIROLOGY,US,THE AMERICAN SOCIETY FOR MICROBIOLOGY, vol. 70, no. 10, October 1996 (1996-10-01), pages 6826 - 6830-6830, XP002110170, ISSN: 0022-538X * |
KAO C C ET AL: "De novo initiation of RNA synthesis by a recombinant flaviridae RNA-dependent RNA polymerase", VIROLOGY,US,ACADEMIC PRESS,ORLANDO, vol. 253, no. 253, 1999, pages 1 - 7-7, XP002110174, ISSN: 0042-6822 * |
LOHMAN V. ET AL.,: "Biochemical and kinetic analyses of NS5B RNA-dependent RNA polymerase of the hepatitis C virus", VIROLOGY, vol. 249, - 1998, pages 108 - 118, XP002141668 * |
LOHMANN V ET AL: "BIOCHEMICAL PROPERTIES OF HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE AND IDENTIFICATION OF AMINO ACID SEQUENCE MOTIFS ESSENTIAL FOR ENZYMATIC ACTIVITY", JOURNAL OF VIROLOGY,US,THE AMERICAN SOCIETY FOR MICROBIOLOGY, vol. 71, no. 11, November 1997 (1997-11-01), pages 8416 - 8428, XP000877461, ISSN: 0022-538X * |
Also Published As
Publication number | Publication date |
---|---|
WO2000040759A9 (en) | 2001-10-11 |
AU2405300A (en) | 2000-07-24 |
WO2000040759A2 (en) | 2000-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002252183A1 (en) | Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases | |
AU2003284689A1 (en) | NUCLEIC ACID CONSTRUCT CONTAINING HEPATITIS C VIRUS (HCV) OF GENOCYPE 2a GENOME-ORIGIN NUCLEIC ACID AND CELL HAVING THE NUCLEIC ACID CONSTRUCT TRANSFERRED THEREINTO | |
WO2003031588A3 (en) | Hepatitis c virus vaccine | |
AU2003240488A1 (en) | Pyrazolo` 1,5a! pyrimidine compounds as antiviral agents | |
WO2003025132A3 (en) | Dna polymerases and mutants thereof | |
AU2003224371A1 (en) | Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same | |
WO2002057425A3 (en) | Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase | |
WO2002059321A3 (en) | Hepatitis c virus replicons and replicon enhanced cells | |
AU2055301A (en) | Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease | |
WO2004007512A3 (en) | Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase | |
WO2004000858A3 (en) | Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase | |
AP2007003918A0 (en) | Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same | |
AU2158000A (en) | Treatment of hepatitis c virus infections with interleukin-10 | |
WO2000040759A3 (en) | Uses of flavivirus rna-dependent rna polymerases | |
AU2291299A (en) | Promoter regions of the mouse and human telomerase rna component genes | |
AU2002250078A1 (en) | Quantitative epstein barr virus pcr rapid assay | |
WO2003015708A8 (en) | Composition and method for treating hiv infection | |
WO2005067454A3 (en) | Combination therapy for treating hepatitis c virus infection | |
IL142288A0 (en) | An in vitro activity assay for human hepatitis b virus (hbv) dna polymerase, and its use for screening for inhibitors of hbv dna polymerase | |
AU2003215826A1 (en) | Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase | |
AU5452300A (en) | Target amplification of nucleic acid with mutant rna polymerase | |
WO2003095971A3 (en) | Posh nucleic acids, polypeptides and related methods | |
WO2001044266A3 (en) | Nucleic acid compounds and screening assays using the same | |
WO2002100900A3 (en) | Human recombinant antibody against the hepatitis c (hcv) non structural ns3 protein, nucleic acid and uses thereof | |
AU2001254563A1 (en) | Internal de novo initiation sites of the hcv ns5b polymerase and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: C2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1/16-16/16, DRAWINGS, REPLACED BY NEW PAGES 1/20-20/20; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |